Estudio comparativo de melatonina contra los tratamientos inmunomoduladores (interferón beta y acetato de glatirámero) en un modelo murino de esclerosis múltiple
Resumen: Introducción: La esclerosis múltiple (EM) es una enfermedad crónica desmielinizante autoinmune del sistema nervioso central (SNC) que produce neuroinflamación; un modelo es la encefalitis autoinmune experimental (EAE). La EM ha sido tratada con interferón beta (IFN-β) y acetato de glatirám...
Main Authors: | E.J. Ramos González, L.J. Ramirez Jirano, D.Z. García Martínez, G.G. Ortiz, L.F. Jave Suárez, C.A. Leal Cortes, O.K. Bitzer Quintero |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Elsevier España
2021-05-01
|
Series: | Neurología |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0213485318300227 |
Similar Items
-
Synthetic Cationic Autoantigen Mimics Glatiramer Acetate Persistence at the Site of Injection and Is Efficacious Against Experimental Autoimmune Encephalomyelitis
by: Jimmy Y. Song, et al.
Published: (2021-01-01) -
Tolerability, adverse events and compliance to glatiramer acetate in 28 patients with multiple sclerosis using the drug continuously for at least six months Tolerabilidade, eventos adversos e aderência ao acetato de glatiramer em 28 pacientes com esclerose múltipla usando a droga continuamente por pelo menos seis meses
by: Ana Patricia Perez Fiore, et al.
Published: (2005-09-01) -
Letter to the Editor Regarding: A Comprehensive Review on Copemyl®
by: Giancarlo Comi, et al.
Published: (2018-11-01) -
Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis
by: Rina Aharoni, et al.
Published: (2021-12-01) -
Papel inmunomodulador de las dietas lipídicas en un modelo murino inmunosuprimido e infectado con Listeria monocytogenes
by: José María Cerón Rodríguez, et al.